| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 63.007 | 54.204 | 72.968 | 75.808 | 81.270 | 92.619 | 82.338 | 87.879 | 97.960 | 112.566 |
| Total Income - EUR | 64.152 | 54.607 | 73.137 | 77.469 | 85.085 | 101.624 | 93.129 | 102.828 | 105.081 | 116.428 |
| Total Expenses - EUR | 60.908 | 50.185 | 64.269 | 73.983 | 78.618 | 90.428 | 86.794 | 98.417 | 99.247 | 111.616 |
| Gross Profit/Loss - EUR | 3.244 | 4.422 | 8.868 | 3.486 | 6.467 | 11.196 | 6.336 | 4.411 | 5.834 | 4.811 |
| Net Profit/Loss - EUR | 3.244 | 3.876 | 8.132 | 2.708 | 5.653 | 10.219 | 5.423 | 3.401 | 4.775 | 4.017 |
| Employees | 4 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Farmaco Gama Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 21.164 | 19.104 | 16.377 | 14.681 | 13.666 | 10.654 | 8.974 | 6.977 | 4.951 | 87.676 |
| Current Assets | 7.802 | 9.491 | 17.220 | 20.249 | 20.038 | 27.827 | 130.076 | 122.690 | 131.108 | 50.536 |
| Inventories | 2.362 | 4.127 | 5.849 | 4.708 | 9.570 | 11.396 | 13.704 | 11.448 | 17.736 | 26.595 |
| Receivables | 4.512 | 2.858 | 11.005 | 15.135 | 8.940 | 14.682 | 108.661 | 110.655 | 112.830 | 11.650 |
| Cash | 928 | 2.506 | 365 | 406 | 1.528 | 1.749 | 7.711 | 586 | 542 | 12.292 |
| Shareholders Funds | 2.180 | 6.033 | 14.063 | 16.513 | 21.846 | 31.651 | 36.372 | 23.663 | 28.367 | 32.225 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 26.787 | 22.562 | 19.534 | 18.418 | 11.859 | 6.830 | 102.678 | 106.728 | 107.691 | 106.707 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmaco Gama Srl